Why Life Sciences Regulatory Systems Are Not Ready for the AI Era
The life sciences industry has spent the better part of a decade modernising its regulatory infrastructure — investing in global regulatory information management (RIM) systems,…
The life sciences industry has spent the better part of a decade modernising its regulatory infrastructure — investing in global regulatory information management (RIM) systems,…
Lately, there has been a lot of talk about the potential use cases for—and benefits of—artificial intelligence (AI) for the pharmaceutical industry. Compared with other…
With agentic AI, the promise is about so much more than process enhancement and greater productivity. It is about redefining a function’s purpose and value,…
AI enabled pharmacovigilance isn’t just about absorbing extra AE case volumes without driving up costs to maintain compliance and mitigate risk. It is also crucial…
Data in life sciences is more than a mere by product of research; it is a driving force behind innovation. By harnessing extensive datasets, organisations…
The biotech industry is undergoing a profound digital transformation, with artificial intelligence (AI), cloud computing, and real-time analytics reshaping drug discovery, personalised medicine, and healthcare…
Did you know that it takes approximately seven years to develop and bring a new drug to market? However, this time can be significantly reduced…
With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start…
In 2022, Swedish researcher Almira Osmanovic Thunström instructed the GPT-3 algorithm to follow a simple directive — “Write an academic thesis in 500 words about…